Francesca Barone - 15 Jan 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Chief Scientific Officer
Signature: /s/ Charles Schoch, as Attorney-in-Fact for Francesca Barone
Issuer symbol: CADL
Transactions as of: 15 Jan 2025
Net transactions value: -$97,783
Form type: 4
Filing time: 17 Jan 2025, 16:30:08 UTC
Previous filing: 10 Jan 2025
Next filing: 14 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CADL	Common Stock	Sale	$97,783	-13,534	-11%	$7.22	110,673	15 Jan 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Content

The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.